Development and Prospect of Genetically Engineered Pharmaceutics
Ya Qiong Huang,Kenneth L. White,De Shun Shi,Xu Jian Chen,Jia Zhou Li,Shi Yuan Zeng,Shi Hua Zhao,Gui Wen Ruan
DOI: https://doi.org/10.4028/www.scientific.net/amr.746.588
2013-01-01
Advanced Materials Research
Abstract:With the rapid development of modern biology and technology, Genetically Engineered Pharmaceutics has become the most important field in modern medicinal industry. Currently, we have taken concern that the Genetically Engineered Pharmaceutics has been a subject of research. As advanced genetically engineered technology, genetic therapy, the point mutation techniques, DNA shuffling, RNA interference (RNAi) technology, the bioinformatics for genome and proteome analyses, the high throughput screening technology, etc. can be applied in the treatment of cancer, and other targeted therapies. A great deal of advanced technologies accelerates the development of genetically engineered pharmaceutics, and plays a key role in genetically engineered pharmaceutics. With the advances in genetically engineered pharmaceutics, we look forward to finding more new drugs, such as the high-value peptides, small functional molecular groups, proteins, especially antibodies, vaccines, enzymes, and therapeutic peptides. These developments continue to secure greater health outcomes of human being at all aspects in the long run. In this article, the development and prospect of Genetically Engineered Pharmaceutics are reviewed, and furthermore, the potential development and huge prospects are also presented.